Go to the content. | Move to the navigation | Go to the site search | Go to the menu | Contacts | Accessibility

| Create Account

Giantin, Mery (2008) Effetti di fattori intrinseci ed estrinseci sull'espressione in vivo ed in vitro degli enzimi farmaco-metabolizzanti epatici del bovino. [Ph.D. thesis]

Full text disponibile come:

Documento PDF

Abstract (english)

Cytochrome P450 superfamily (CYP) comprises an ubiquitous enzyme system, with the highest concentration found in the liver. These enzymes play a crucial role in the metabolism of xenobiotics and endogenous compounds. Their primary role is converting lipophilic compounds to more polar and hydrophilic metabolites by means of oxidative, reductive and hydrolitic reactions. Products of these chemical reactions can then be conjugated with polar endogenous compounds and readily excreted by the organism (Ioannides, 2006). The evaluation of liver biotrasformation pathways in veterinary species, but expecially in cattle, is considered very important, particularly for the presence of potentially harmful residues in foodstuff of animal origin (Sivapathasundaram et al., 2001). Thus, very few informations about bovine metabolism are actually available in literature and they primarily focused on catalytic activities and protein expression data (Sivapathasundaram et al., 2001; Nebbia et al., 2003; Szotáková et al., 2004; Dacasto et al., 2005). Recently, increasing importance has been given to toxicogenomics, the science which studies the correlations between genome structure, activity and toxicological effects of xenobiotics (Aardema and McGregor, 2002). The recent advances in molecular biology have resulted in the possibility to set up innovative, sensitive and specific biomolecular tecniques, that can be successfully applied in Drug Metabolism (DM) studies (Tugwood et al., 2003).
As a consequence, the aim of the present research project consists on the application of some recent biomolecular techniques, as the quantitative Real Time PCR (Q RT-PCR), in order to study the expression and the regulation of some genes involved in bovine DM.
The following methodological approach has been adopted: firstly a bibliographic search to identify genes involved in xenobiotics metabolism and then, collection of the corresponding available mRNA sequences from databases; clonage and sequencing of bovine sequences not yet available; primers design and set up of bovine-specific Q RT-PCR assays; total RNA isolation from cattle liver samples either of control or experimentally treated with illicit growth promoters; finally, the application of Q RT-PCR assays for the relative quantitation of selected transcripts (genes involved in xenobiotics metabolism and/or transcription factors) in: (a) beef cattle belonging to different meat cattle breeds; (b) veal calves and beef cattle illegally treated with dexamethasone (DEX) administered alone per os or intramuscularly, or in association with 17ß-oestradiol (E2: this last treatment has been considered only in beef cattle); (c) in primary cultures of bovine hepatocytes incubated with endogenous/exogenous precursors of steroids and in beef cattle illegally treated with the same molecules, in order to compare in vivo/in vitro effects. Messanger RNA results were successfully compared and/or correlated with catalytic activity data obtained by using marker substrates known as specific for each considered CYP isoform or phase II enzyme, but also with protein expression data (CYP1A, 2B, 2C, 2E and 3A immunoblotting and semiquantitative densitometric analysis).
Partial sequences coding for bovine CYP2B, CYP4A, UGT1A4, RXR?, GR, HNF4? and 17ßHSDII genes (all involved in DM and its regulation) have been cloned, sequenced and submitted to GenBank; furthermore Q RT-PCR assays for a total of 28 transcripts have been designed and set up.
Forementioned assays were applied to evaluate the hepatic biotransformative pattern in 18-20 months old beef cattle belonging to three different meat cattle breeds (Charolais, CH; Piedmontese, PM; Blonde d'Aquitaine, BA). Statistically significant differences (P<0.05 or less) have been noticed in CYP1A1, CYP1A2, CYP2B6, CYP2C9, CYP2C18, CYP3A4, UGT1A1, UGT1A6, UGT2B17, GSTA1, GSTM1, GSTP1 mRNA expression. In particular, CH presented the lowest mRNA expression for all the forementioned transcripts except for UGT1A6, if compared with the similar expression profile of PM and BA. Results obtained at the pre-transcriptional level were confirmed at the post-translational one by immunoblotting, only in the case of CYP2B and CYP3A: in this respect, protein expression data for these two enzymes demonstrated the same trend among breeds (CH<PM<BA). The in vitro metabolism of specific model substrates for each isoform, instead, did not agree with Q RT-PCR data (except in some instances), but, on the contrary, presented an opposite behaviour: in fact, CH appeared to be the breed gifted of the lower gene expression but of the higher biotransformation capability. This result could be probably ascribed to a more efficient catalytic system or to the presence of polymorphisms. Furthermore, the correlation analysis between single enzyme gene expression and the corresponding catalytic activity has been performed: for some isoforms a good correlation has been evidenced. Present results confirmed the breed as one of the internal factors that might modulate the metabolism in cattle.
The same Q RT-PCR assays have been applied in other two experiences, where 15-18 months old beef cattle have been administered with illicit compounds; the aim of the present approach was to evaluate the effects of these substances on liver metabolism and to identify possible indirect biomarkers of treatment.
In the first experiment, "Marchigiani" beef cattle were treated with DEX per os (TPD group) or intramuscularly (BPD group), whereas in the second study French crossbred cattle were administered DEX alone (Dde group) or in combination with E2 (DEde group). Gene expression data pointed out a significant induction of CYP1A1, CYP1A2 and CYP3A4 mRNA in DEde group, while a consistent inhibition of CYP2B6 e CYP2E1 was noticed in all treated groups. As regards the tested phase II enzymes, GSTA1 was induced in BPD and DEde groups, and SULT1A1 in TPD and DEde ones. Finally, among nuclear receptors, an increase either of CAR and RXR? expression in TPD and DEde groups or ER? (only in DEde group) was noticed. The design and the application of a 28 transcripts PCR-Array of hepatic metabolism in experiments regarding illicit treatments allowed the identification of some potential candidate genes that could be used in the future as indirect biomarkers on field, although only after a validation step.
The same approach (only for some phase I enzymes and corresponding transcription factors) has been used to complete another experiment, in which veal calves were treated only with DEX per os or intramuscularly: the evidenced effects were completely different from other ones collected in beef cattle, probably for physiological differences (age, diet, anatomy and physiology of the gastro-enterical apparatus) that are likely to modulate DEX pharmacokinetics but also for difficulties strictly related with this particular kind of farming (stress conditions and iron-deprived diet). No statistically significant differences were observed in chosen CYPs and nuclear receptors gene expression, except for GR, induced in the group of animals treated intramuscularly with DEX. Furthermore, the CYP3A protein expression was inhibited in both treated groups, confirming the trend observed at both gene expression and catalytic activity levels.
Finally, the effects of some endogenous/exogenous precursors of sexual steroids on some metabolism enzymes and transcription factors gene expression have been evaluated, by comparing one in vitro and one in vivo system. Primary cultures of bovine hepatocytes, incubated for 6 hours with 100 ’µM ADD or DHEA, and 15-18 months old beef cattle ("Valdostana" breed), treated with the same compounds at the dosage of 50 mg/pro capite once a week for 5 weeks, were used. Quantitative Real Time PCR results evidenced that the in vivo treatments with the forementioned molecules did not cause relevant effects (except for PXR and PPAR? inhibition in the group treated with DHEA), confirming both catalytic activities and immunoblotting results. On the contrary, in the in vitro system, DHEA caused a 1,5 - 4 fold induction of CYP2C9, GSTA1, DHEA-ST, 17ßHSD type II, CAR, PXR, RXR? and PPAR? mRNA expression, and a significant inhibition of CYP1A1, CYP2E1 and UGT2B17. The incubation with ADD, instead, evidenced only a significant inhibition of CYP1A1 expression. The different behavior observed in the in vivo and in vitro systems could be probably due to the dose applied and to the fact that the in vitro system represents a semplification of the organism in toto and that mimics with a lot of difficulties the pharmaco- and toxicological processes that normally happen in vivo (Freshney, 2001). Nonetheless, in vitro alternative methods are valid systems because they are rapid, riproducible and could substitute field experiments, that necessitate many animals. As a whole, other experiences, to standardize the protocol of hepatocytes isolation, are requested in order to reduce the inter-culture variability observed.

Statistiche Download - Aggiungi a RefWorks
EPrint type:Ph.D. thesis
Tutor:Dacasto, Mauro
Data di deposito della tesi:31 January 2008
Anno di Pubblicazione:31 January 2008
Key Words:Citocromo P450; enzimi coniugativi; fattori di trascrizione; espressione genica; Real Time PCR; bovino; trattamenti illeciti; razza; epatociti in coltura primaria.
Settori scientifico-disciplinari MIUR:Area 07 - Scienze agrarie e veterinarie > VET/07 Farmacologia e tossicologia veterinaria
Struttura di riferimento:Dipartimenti > pre 2012 - Dipartimento di Sanità pubblica, Patologia comparata ed Igiene veterinaria
Codice ID:252
Depositato il:24 Nov 2008
Simple Metadata
Full Metadata
EndNote Format


I riferimenti della bibliografia possono essere cercati con Cerca la citazione di AIRE, copiando il titolo dell'articolo (o del libro) e la rivista (se presente) nei campi appositi di "Cerca la Citazione di AIRE".
Le url contenute in alcuni riferimenti sono raggiungibili cliccando sul link alla fine della citazione (Vai!) e tramite Google (Ricerca con Google). Il risultato dipende dalla formattazione della citazione.

1. Aardema MJ and MacGregor JT (2002) Toxicology and genetic toxicology in the new era of “toxicogenomics”: impact of “-omics”technologies. Mutation Research 499:13-25. Cerca con Google

2. AAVV (IV edizione 2003) Dizionario del Medicinale Veterinario, Editore Point Veterinarie, Italie Cerca con Google

3. Abraham G, Gottschalk J and Ungemach FR (2004) Possible role of dexamethasone in sensitizing the beta-2-adrenergic receptor system in vivo in calves during concomitant treatment with clenbuterol. Pharmacology 72:196-204. Cerca con Google

4. Aguiar M, Masse R and Gibbs BF (2005) Regulation of cytochrome P450 by posttranslational modification. Drug Metabolism Review 37:379-404. Cerca con Google

5. Akingbemi BT (2005) Estrogen regulation of testicular function. Reproductive Biology and Endocrinology 51:1-13. Cerca con Google

6. Akiyama TE and Gonzalez FJ (2003) Regulation of P450 genes by liver-enriched transcription factors and nuclear receptors. Biochimica et Biophysica Acta 1619:223-234. Cerca con Google

7. Alberti CG and Villa L (1984) Chimica Farmaceutica Org. Edit. Medico-Farmaceutica, Milano, Italia 1:47-49. Cerca con Google

8. Aninat C, Piton A, Glaise D, Le Charpentier T, Langouët S, Morel F, Gugen-Guillouzo C and Guillouzo A (2006) Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma Hepa RG cells. Drug Metabolism and Disposition 34:75-83. Cerca con Google

9. Antoine B, Boutin JA and Siest G (1988) Further validation of the Mulder and van Doorn kinetic procedure for the measurement of microsomal UDP-glucuronosyltransferase activities. Biochemical Journal 252:930-931. Cerca con Google

10. Auchus RJ (2004) Overview of dehydroepiandrosterone biosynthesis. Seminars in Reproductive Medicine 22:281-288. Cerca con Google

11. Badawi AF, Cavalieri EL and Rogan EG (2000) Effect of chlorinated hydrocarbons on expression of cytochrome P450 1A1, 1A2 and 1B1 and 2- and 4-hydroxylation of 17ß-estradiol in female Sprague Dawley rats. Carcinogenesis 21:1593-1599. Cerca con Google

12. Baisch H, Otto U and Fack H (1998) Growth of human prostate carcinomas with and without hormone alpha dehydroepiandrosterone in nude mice. European Urology 34:505-515. Cerca con Google

13. Ball GF and Balthazard J (2004) Hormonal regulation of brain circuits mediating male sexual behavior in birds. Physiology and Behavior 83:329-346. Cerca con Google

14. Baranczewski P, Stanczak A, Kautiainen A, Sandin P and Edlund PO (2006) Introduction to early in vitro identification of metabolites of new chemical entities in drug discovery and development. Pharmacological Reports 58:311-352. Cerca con Google

15. Battle T and Stacey G (2001) Cell cultures models for Hepatotoxicology. Cell Biology and Toxicology 17:287-299. Cerca con Google

16. Baulieau EE, Thomas G, Legrain S, Lahlou N, Roger M, Debuire B, Faucounau V, Girard L, Hervy MP, Latour F, Leaud MC, Mokrane A, Pitti-Ferrandi H, Trivalle C, de Lacharrière O, Nouveau S, Rakoto-Arison B, Souberbielle JC, Raison J, Le Bouc Y, Raynaud A, Girerd X and Forette F (2000) Dehydroepiandrosterone (DHEA), DHEA sulfate and ageing: contribution of DHEAge study to a sociobiomedical issue. Proceedings of the National Academy of Science of the United States of America 97:4279-4284. Cerca con Google

17. Beerman DH, Hogue DE, Fishell VK, Dalrymple RH and Ricks CA (1986) Effects of cimaterol and fishmeal on performance, carcass characteristics and skeletal muscle growth in lambs. Journal of Animal Science 62:370-380. Cerca con Google

18. Bergmeyer HU, Bernt E and Hess B (1963) Lactic dehydrogenase. In: Methods of Enzymatic Analysis. Edited by Bergmeyer HU, Academic Press, New York, 736-741. Cerca con Google

19. Bertilsson PM, Olsson P and Magnusson KE (2001) Cytokines influence mRNA expression of cytochrome P450 3A4 and MDR1 in intestinal cells. Journal of Pharmaceutical Science 90:638-646. Cerca con Google

20. Bogaards JJP, Bertrand M, Jackson P, Oudshoorn MJ, Weaver RJ, Van Bladeren PJ and Walther B (2000) Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica 30:145-151. Cerca con Google

21. Buisson C, Hebestreit M, Weigert AP, Heinrich K, Fryc H, Flenker U, Banneke S, Prevost S, Andre F, Schaenzer W, Houghton E and Le Bizec B (2005) Application of stable carbon isotope analysis to the detection of 17 ß-estradiol administration to cattle. Journal of Chromatography 1093:69-80. Cerca con Google

22. Burchell B (2003) Genetic variation of human UDP-glucuronosyltransferase: implications in disease and drug glucuronidation. American Journal of Pharmacogenomics 3:37-52. Cerca con Google

23. Burchell B and Coughtrie MWH (1989) UDP-glucuronosyltransferases. Pharmacology and Therapeutics 43:261-289. Cerca con Google

24. Bustin SA (2000) Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. Journal of Molecular Endocrinology 25:169-193. Cerca con Google

25. Bustin SA (2002) Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. Journal of Molecular Endocrinology 29:23-39. Cerca con Google

26. Bustin SA and Nolan T (2004) Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. Journal of Biomolecular Tecniques 15:155-166. Cerca con Google

27. Bustin SA, Benes V, Nolan T and Pfaffl MW (2005) Quantitative real-time RT-PCR - a perspective. Journal of Molecular Endocrinology 34:597-601. Cerca con Google

28. Cantiello M (2003) Effetti di trattamenti illeciti sul benessere animale e sugli enzimi farmaco-metabolizzanti in animali da reddito. Tesi di Dottorato, Torino. Cerca con Google

29. Cantiello M, Carletti M, Cannizzo FT, Nebbia C, Bellino C, Pié S, Oswald IP, Bollo E and Dacasto M (2007) Effects of an illicit cocktail on serum immunoglobulins, lymphocyte proliferation and cytokine gene expression in veal calf. Toxicology 242:39-51. Cerca con Google

30. Cantiello M, Carletti M, Dacasto M, Capolongo F, Gardini G, Cascio P, Martin PGP, Pineau T and Nebbia C (2006) Catalytic, immunochemical and molecular characterization of xenobiotic-metabolising enzyme modulation by Phenobarbital in the bovine liver. Journal of Veterinary Pharmacology and Therapeutics 29:115-116. Cerca con Google

31. Cantiello M, Carletti M, Dacasto M, Martin PGP, Pineau T, Capolongo F, Gardini G and Nebbia C (2008a) Inhibition of in vitro xenobiotic- and testosterone metabolism in liver microsomes from veal calves experimentally treated with a combination of 17 ß-estradiol, clenbuterol and dexamethasone. Food and Chemical Toxicology (submitted) Cerca con Google

32. Cantiello M, Giantin M, Bollo E, Nebbia C, Lasserre F, Martin P, Pineau T and Dacasto M (2005) Cloning and sequencing of some relevant drug metabolism genes in cattle: the Programma Galileo 2003 summary report. Pharmacologyonline 3:66-76. Cerca con Google

33. Cantiello M, Giantin M, Carletti M, Capolongo F, Lasserre F, Bollo E, Nebbia C, Martin PGP, Pineau T and Dacasto M (2008b) Effect of the illicit administration of dexamethasone upon the liver cytochrome P450 3A expression in veal calves. Biochemical Pharmacology (manuscript in preparation) Cerca con Google

34. Capolongo F, Merlanti R, Cibin V, De Liguoro M and Montesissa C (2003) In vivo hormone treatments in calves: effects on in vitro hydroxylation of testosterone. Journal of Veterinary Pharmacology and Therapeutics. 26:159-160. Cerca con Google

35. Capolongo F, Tapparo M, Merlanti R, Ravarotto L, Tealdo E, Gallina G, Montesissa C and Dacasto M (2007) Illicit treatments in cattle and urinary 6beta-hydroxycortisol/cortisol ratio. Analytica Chimica Acta 586:228-232. Cerca con Google

36. Caron E, Rioux N, Nicolas O, Lebel-Talbot H and Hamelin BA (2005) Quantification of the expression and inducibility of 12 rat cytochrome P450 isoforms by quantitative RT-PCR. Journal of Biochemical and Molecular Toxicology 19:368-378. Cerca con Google

37. Casley WL, Menzies JA, Girard M, Larocque L, Mousseau N, Whitehouse LW and Moon TW (1997) Differences in caffeine 3-demethylation activity among inbred mouse strains: a comparison of hepatic cyp1a2 gene expression between two inbred strains. Fundamental and Applied Toxicology 40:228-237. Cerca con Google

38. Catania JR, McGarrigle BP, Rittehouse-Olson K and Olson JR (2007) Induction of CYP2B and CYP2E1 in precision-cut rat liver slices cultured in defined medium. Toxicology in vitro 21:109-115. Cerca con Google

39. Choo JJ, Emery PW and Rotwell NJ (1991) Dose-dependent effects of a steroid, nandrolone phenylpropionate (Durabolin), on body composition and muscle protein metabolism in female fats. Annals of nutrition and metabolism 35:141-147. Cerca con Google

40. Cinelli S, Fralezza A, Meli C, Ciliutti P and Vericat JA (1991) Alternative methods in toxicology tests: in vitro toxicity. Cytotechnology 5:51-54. Cerca con Google

41. Clarke ML, Harvey DG and Humphreys JR (II Edizione 1981) In: Balliére and Tindall, Veterinary Toxicology, London. Cerca con Google

42. Commissione dell’Unione Europea, Decisione della Commissione 2002/657/CE. Official Journal of European Communities, L221 (2001) 8 Cerca con Google

43. Commissione dell’Unione Europea, Direttiva Comunitaria 2003/74/CE. Official Journal of the European Communities, L 262 (2003) 17-21. Cerca con Google

44. Commissione dell’Unione Europea, Direttiva del Consiglio 96/22/CE. Official Journal of the European Communities, L125 (1996) 3 Cerca con Google

45. Commissione dell’Unione Europea, Direttiva del Consiglio 96/23/CE. Official Journal of the European Communities, L125 (1996) 10 Cerca con Google

46. Commissione dell’Unione Europea, Regolamento del Consiglio 2377/90/CE. Gazzetta Ufficiale, L224 (1990) 1 Cerca con Google

47. Commissione dell’Unione Europea, Regolamento del Parlamento Europeo e del Consiglio 853/2004/CE. Official Journal of the European Communities, L139 (2004) 55 Cerca con Google

48. Commissione dell’Unione Europea, Regolamento del Parlamento Europeo e del Consiglio 854/2004/CE. Official Journal of the European Communities, L226 (2004) 83 Cerca con Google

49. Correa F, García N, García G and Chávez E (2003) Dehydroepiandrosterone as an inducer of mitochondrial permeability transition. Journal of Steroid Biochemistry and Molecular Biology 87:279-284. Cerca con Google

50. Coulet AS, Le Bizec B, Boerlen F, Monteau F and André F (1998) Calf primary hepatocyte culture as a tool for anabolic steroid metabolism studies. Analyst 123:2489-2492. Cerca con Google

51. Coulet M, Eeckhoutte C, Larrieu G, Sutra JF, Hoogenboom LAP, Huveneers-Oorsprong MBM, Kuiper H, Castell JV, Alvinerie M and Galtier P (1998) Comparative metabolism of thiabendazole in cultured hepatocytes from rats, rabbits, calves, pigs, and sheeps, including the formation of bound residues. Journal of Agricultural Food and Chemistry 46:742-748. Cerca con Google

52. Courtheyn D, Le Bizec B, Brambilla G, De Brabander HF, Cobbaert E, Van de Wiele M, Vercammen J and De Whash K (2002) Recent developments in the use and abuse of growth promoters. Analytica Chimica Acta 473:71-82. Cerca con Google

53. Cui X, Thomas A, Han Y, Palamanda J, Montgomery D, White RE, Morrison RA and Cheng KC (2005) Quantitative PCR assay for cytochrome P450 2B and 3A induction in rat precision-cut liver slices: correlation study with induction in vivo. Journal of Pharmacological and Toxicological Methods 52:234-243. Cerca con Google

54. Cuzzocrea S, Bruscoli S, Crisafulli C, Mazzon E, Agostini M, Muià C, Esposito E, Di Virgilio R, Meli R, Vegeto E, Maggi A and Riccardi C (2007) Estrogen receptor antagonist fulvestran (ICI 182,780) inhibits the anti-inflammatory effect of glucocorticoids. Molecular Pharmacology 71:132-144. Cerca con Google

55. Dacasto M, Eeckhoutte C, Capolongo F, Dupuy J, Carletti M, Calléja C, Nebbia C, Alvinerie M and Galtier P (2005) Effect of breed and gender on bovine liver cytochrome P450 3A (CYP3A) expression and inter-species comparison with other domestic ruminants. Veterinary Research 36:179-190. Cerca con Google

56. Dawling S, Hachey DL, Roodi N and Parl FF (2004) In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol. Chemical Research in Toxicology 17:1258-1264. Cerca con Google

57. Daxenberger A, Ibarreta D and Meyer HH (2001) Possible health impact of animal oestrogen in food. Human Reproduction Update 7:340-355. Cerca con Google

58. De Brabander HF, Poelmans S, Schilt R, Stephany RW Le Bizec B, Draisci R, Sterk SS, Van Ginkel LA, Courtheyn D, Van Hoof N, Macri A and De Wasch K (2004) Presence and metabolism of the anabolic steroid boldenone in various animal species: a review. Food Additives and Contaminants 21:515-525. Cerca con Google

59. De Longueville F Surry D, Menenes-Lorente G, Bertholet V, Talbot V, Evrard S, Chandelier N, Pike A, Worboys P, Rasson JP, Le Bourdellès B and Remacle J (2002) Gene expression profiling of drug metabolism and toxicology markers using a low-density DNA microarray. Biochemical Pharmacology 64:137-149. Cerca con Google

60. Decker C, Sugiyama K, Underwood M and Correia MA (1986) Inactivation of rat hepatic cytochrome P-450 by spironolactone. Biochemical and Biophysical Research Communications 136:1162-1169. Cerca con Google

61. Derendorf H and Hochhaus G (1995) Handbook of pharmacokinetic/pharmacodynamic correlation. CRC Press, USA Cerca con Google

62. Dickson WM (2002) Ghiandole endocrine. In: Swenson MJ, Reece WO, Duke’s Fisiologia degli Animali Domestici, Idelson-Gnocchi, Italia. Cerca con Google

63. Donato MT (2004) Qué es el citocromo P-450 y cómo funziona. In: Cascales Angosto M, Gómez- Lechón MJ, Citocromo P-450, Istituto de España, Real Accademia Nacional de Farmacia, Realigraf S.A., Madrid, España. Cerca con Google

64. Donato MT and Castell JV (2003) Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism. Clinical Pharmacokinetics 42:153-178. Cerca con Google

65. Donato MT and O’Connor JE (2004) Metodos de evaluacion del citocromo P450 y des papel en el metabolismo de los xenobioticos. In: Cascales Angosto M, Gómez-Lechón MJ, Citocromo P-450, Istituto de España, Real Accademia Nacional de Farmacia, Realigraf S.A., Madrid, España. Cerca con Google

66. Draisci R, Palleschi L, Ferretti E, Lucentini L and Delli Quadri F (2003) Confirmatory analysis of 17 ß-boldenone, 17 ?-boldenone and androsta-1,4-diene-3,17-dione in bovine urine by liquid chromatography-tandem mass spectrometry. Journal of Chromatography B 789:219-226. Cerca con Google

67. Duanmu Z, Kocarek TA and Rouge-Morris M (2001) Transcriptional regulation of rat hepatic aryl sulfotransferase (SULT1A1) gene expression by glucocorticoids. Drug Metabolism and Disposition 29:1130-1135. Cerca con Google

68. Duanmu Z, Locke D, Smigelski J, Wu W, Dahn MS, Falany CN, Kocarek TA and Runge-Morris M (2002) Effects of dexamethasone on aryl (SULT1A1)- and Hydroxysteroid (SULT2A1)-sulfotransferase gene expression in primary cultured human hepatocytes. Drug Metabolism and Disposition 30:997-1004. Cerca con Google

69. Echchgadda I, Song CS, Oh TS, Cho SH, Rivera O and Chatterjee B (2004b) Gene regulation for the senescence marker protein DHEA-sulfotransferase by the xenobiotic-activated nuclear pregnane X receptor (PXR). Mechanisms of Ageing and Development 125:733-745. Cerca con Google

70. Echchgadda I, Song CS, Roy AK and Chatteriee B (2003) Xenobiotic induction of human-sulfotransferase gene transcription: role of the xenosensing pregnane X receptor (PXR) and constitutive androstane receptor (CAR). Proceedings of the 85th Annual Meeting of the Endocrine Society, 19th - 22nd June 2003, Philadelphia, PA. Cerca con Google

71. Echchgadda I, Song CS, Roy AK and Chatteriee B (2004a) Dehydroepiandrosterone sulfotransferase is a target for transcriptional induction in the Vitamin D receptor. Molecular Pharmacology 65:720-729. Cerca con Google

72. Eeckhoutte C, Giuliano Albo A, Carletti M, Rossetto Giaccherino A, Galtier P, Nebbia C and Dacasto M (2002) Time-dependent variations of drug-metabolising enzyme activities (DMEs) in primary cultures of rabbit hepatocytes. Toxicology in Vitro 16:375-382. Cerca con Google

73. El Sankary W, Bombail V, Gordon Gibson G and Plant N (2002) Glucocorticoid-mediated induction of CYP3A4 is decreased by disruption of a protein: DNA interaction distinct from the pregnane X receptor response element. Drug Metabolism and Disposition 30:1029-1034. Cerca con Google

74. El-Ali J, Sorger PK and Jensen KF (2006) Cells on chips. Nature 442:403-411. Cerca con Google

75. Ellman GL (1959) Tissue sulphydril groups. Archives of Biochemistry and Biophysics 82:70-77. Cerca con Google

76. Eriksson M, Karlsson HJ, Westman G and Akerman B (2003) Groove-binding unsymmetrical cyanine dyes for staining of DNA: dissociation rates in free solution and electrophoresis gels. Nucleic Acids Research 31:6235-6242. Cerca con Google

77. Falany CN (1997) Enzymology of human cytosolic sulfotransferases. FASEB Journal 11:206-216. Cerca con Google

78. Fey A, Eichler S, Flavier S, Christen R, Höfle MG and Guzmán CA (2004) Establishment of a real-time PCR-based approach for accurate quantification of bacterial RNA targets in water, using Salmonella as a model organism. Applied and Environmental Microbiology 70:3618-3623. Cerca con Google

79. Flaws JA and Bush TL (1998) Racial differences in drug metabolism: an explanation for the higher breast cancer mortality in blacks? Medical Hypotheses 50:327-329. Cerca con Google

80. Freshney I (2001) Application of cell cultures to toxicology. Cell Biology and Toxicology 17:213-230. Cerca con Google

81. Frova C (2006) Glutathione transferases in the genomics era: new insights and perspectives. Biomolecular Engineering 23:149-169. Cerca con Google

82. Furukawa M, Nishimura M, Ogino D, Chiba R, Ikai I, Ueda N, Naito S, Kuribayashi S, Moustafa MA, Uchida T, Sawada H, Kamataki T, Funae Y and Fukumoto M (2004) Cytochrome P450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver. Cancer Science 95:520-529. Cerca con Google

83. Furuta S, Kamada E, Suzuki T, Sugimoto T, Kawabata Y, Shinozaki Y and Sano H (2001) Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole. Xenobiotica 31:1-10. Cerca con Google

84. Gardini G, Del Boccio P, Colombatto S, Testore G, Corpillo D, Di Ilio C, Urbani A and Nebbia C (2006) Proteomic investigation in the detection of the illicit treatment of calves with growth-promoting agents. Proteomics 6:2813-2822. Cerca con Google

85. Garfinkle D (1958) Studies on pig liver microsomes. Enzymatic and pigment composition of different microsomal fractions. Archives of Biochemistry and Biophysics 77:493-509. Cerca con Google

86. Gerhold D, Lu M, Xu J, Austin C, Caskey CT and Rushmore T (2001) Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays. Physiological Genomics 5:161-170. Cerca con Google

87. Giantin M, Carletti M, Capolongo F, Nebbia C and Dacasto M (2006) Expression of liver cytochrome P450 drug metabolizing enzymes in different meat cattle breeds. Journal of Veterinary Pharmacology and Therapeutics 26:117. Cerca con Google

88. Giantin M, Carletti M, Capolongo F, Pegolo S, Lopparelli RM, Gusson F, Nebbia C, Cantiello M, Martin P, Pineau T and Dacasto M (2008) Effect of breed upon cytochrome P450s and phase II enzymes expression in cattle liver. Drug Metabolism and Disposition (submitted) Cerca con Google

89. Gibson UE, Heid CA and Williams PM (1996) A novel method for real-time quantitative RT-PCR. Genome Research 6:995-1001. Cerca con Google

90. Ginzinger DG (2002) Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Experimental Hematology 30:503-512. Cerca con Google

91. Giulietti A, Overberg L, Valkx D, Decallonne B, Buillon R and Mathieu C (2001) An overview of real-time quantitative pcr: applications to quantify cytokine gene expression. Methods 25:386-401. Cerca con Google

92. Glockner R, Steinmetzer P, Lupp A, Danz M and Muller D (2002) In vitro induction of cytochrome P450 2B1- and 3A1-mRNA and enzyme immunostaining in cryopreserved precision-cut rat liver slices. Toxicology 176:187-193. Cerca con Google

93. Gómez-Lechón MJ (2004) Regulatión de citocromo P-450 hepático en situaciones fisiopatolágicas: inflamación y regeneración hepatica. In: Cascales Angosto M, Gómez-Lechón MJ, Citocromo P-450, Istituto de España, Real Accademia Nacional de Farmacia, Realigraf S.A., Madrid, España. Cerca con Google

94. Gorski JC, Vannaprasaht S, Hamman MA, Ambrosius WT, Bruce MA, Haehner-Daniels B and Hall SD (2003) The effect of age, sex and rifampicin administration on intestinal and hepatic cytochrome P450 3A activity. Clinical Pharmacology and Therapeutics 74:275-287. Cerca con Google

95. Granata A, Pegolo S, De Bona C, Merlanti R, Montesissa C, Dacasto M and Capolongo F (2007) Validation of a HPLC method for the determination of cytochrome P450 2C (CYP2C) activity in bovine liver microsomes. Proceedings of the 15th International Conference on Cytochrome P450, Bled, Slovenia, June 17th-21st , 155. Cerca con Google

96. Greger DL, Philipona C and Blum JW (2006) Ontogeny of mRNA abundance of nuclear receptors and nuclear receptor target genes in young cattle. Domestic Animal Endocrinology 31:76-87. Cerca con Google

97. Griffin D (1999) Dietary management. In: Howard J, Current Veterinary Theraphy: Food Animal Practice, Saunders Company, USA. Cerca con Google

98. Grifin JE and Ojeda SR (V edizione 2004) In: Textbook of Endocrine Physiology, Oxford University Press, New York, NY, 228-233. Cerca con Google

99. Groot MJ and Biolatti B (2004) Histophatological effects of boldenone in cattle. Journal of Veterinary Medicine A 51:58-63. Cerca con Google

100. Groot MJ, Berende PLM, Schilt R, Lommen A and Huf FA (1992) Influence of clenbuterol alone and in combination with natural hormones on prostate histology in male goat kids. Archiv fur Lebensmittelhygiene 43:110-114. Cerca con Google

101. Groot MJ, Schilt R, Ossenkoppele JS, Berende PL and Haasnoot W (1998) Combinations of growth promoters in veal calves: consequences for screening and confirmatory methods. Journal of Veterinary Medicine 45:425-440. Cerca con Google

102. Gruber FP and Hartung T (2004) Alternatives to animal experimentation in basic research. Altex 21:3-31. Cerca con Google

103. Gu S, Ripp SL, Prough RA and Geoghegan TE (2003) Dehydroepiandrosterone affects the expression of multiple genes in rat liver including 11 ß-hydroxysteroid dehydrogenase type 1: a cDNA array analysis. Molecular Pharmacology 63:722-731. Cerca con Google

104. Guengerich FP (2003) Cytochromes P450, drugs, and diseases. Molecular Interventions 3:194-204. Cerca con Google

105. Guillemette C, Bélanger A and Lépine J (2004) Metabolic inactivation of estrogens in breast tissue by UDPglucuronosyltransferase enzymes: an overview. Breast Cancer Research 6:246-254. Cerca con Google

106. Gusson F, Carletti M, Giuliano Albo A, Dacasto M and Nebbia C (2006) Comparison of hydrolitic and conjugative biotransformations pathways in horse, cattle, pig, broiler chick, rabbit and rat liver subcellular fractions. Veterinary Research Communications 30:271-283. Cerca con Google

107. Habig WH, Pabst MJ and Jakoby WB (1974) Glutathione-S-transferase, the first enzymatic step in mercapturic acid formation. Journal of Biological Chemistry 249:7130-7139. Cerca con Google

108. Haduch A, Wójcikowski J and Wladyslawa AD (2005) Effect of short- and long-term treatment with antidepressant drugs on the activity of rat CYP2A in the liver. Pharmacological Reports 57:774-781. Cerca con Google

109. Hahn ME (2002) Aryl hydrocarbon receptors: diversity and evolution. Chemical and Biological Interactions 141:131-160. Cerca con Google

110. Hakkola J, Pasanen M, Pelkonen O, Hukkanen J, Evisalmi S and Anttila S (1997) Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells. Carcinogenesis 18:391-397. Cerca con Google

111. Hamano Y, Kume K, Yamazaki S, Kobayashi S and Terashima Y (1998) Combined effects of clenbuterol and various concentrations of protein on performance of broiler chickens. British Poultry Science 39:117-122. Cerca con Google

112. Hanioka N, Jinno H, Nishimura T and Ando M (1998) Suppression of male-specific cytochrome P450 isoforms by bisphenol A in rat liver. Archives of toxicology 72:387-394. Cerca con Google

113. Hanrahan JP, Quirke JF, Bomann W, Allen P, McEwan J, Fitzsimons J, Kotzian J and Roche JF (1986) ß-agonists and their effect on growth and carcass quality. In: Recent advances in animal nutrition, Haresign W and ColeDJA Eds, Butterworths, London, 125-38. Cerca con Google

114. Hari Kumar KB and Kuttan R (2006) Inhibition of drug metabolizing enzymes (cytochrome P450) in vitro as well as in vivo by Phyllanthus amarus SCHUM & THONN. Biological and Pharmaceutical Bulletin 29:1310-1313. Cerca con Google

115. Hariparsad N, Sane RS, Strom SC and Desai PB (2005) In vitro methods in human drug biotransformation research: implications for cancer chemiotherapy. Toxicology In Vitro 20:135-153. Cerca con Google

116. He XJ, Ejiri N, Nakayama H and Doi K (2005a) Effects of pregnancy on CYPs protein expression in rat liver. Experimental and Molecular Pathology 78:64-70. Cerca con Google

117. He XJ, Ejiri N, Nakayama H and Doi K (2005b) Changes in cytochrome P450 isoenzymes (CYPs) protein levels during lactation in rat liver. Experimental and Molecular Pathology 79:224-228. Cerca con Google

118. Higuchi R, Dollinger G, Walsh PS and Griffith R (1992) Simultaneous amplification and detection of specific DNA-sequences. Biotecnologies 10:413-417. Cerca con Google

119. Hoch U, Zhang Z, Kroetz DL and Ortiz de Montellano PR (2000) Structural determination of the substrate specificities and regioselectivities of the rat and human fatty acid omega-hydroxylases. Archives of Biochemistry and Biophysics 373:63-71. Cerca con Google

120. Honkakoski P and Negishi M (1997) Characterization of a phenobarbital-responsive enhancer module in mouse P450 Cyp2b10 gene. Journal of Biological Chemistry 272:14943-14949. Cerca con Google

121. Honkakoski P and Negishi M (2000) Regulation of cytochrome P450 (CYP) genes by nuclear receptors. Biochemical Journal 347:321-337. Cerca con Google

122. Honkakoski P, Zelko I, Sueyoshi T and Negishi (1998) The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Molecular Cell Biology 18:5652-5658. Cerca con Google

123. Huang W, Lin YS, McConn DJ, Calamia JC, Totah RA, Isoherranen N, Glodowski M and Thummel KE (2004) Evidence of significant contribution from CYP3A5 to hepatic drug metabolism. Drug Metabolism and Disposition 32:1434-1445. Cerca con Google

124. Iber H, Chen Q, Sewer M and Morgan ET (1997) Regulation of hepatic cytochrome P450 2C11 by glucocorticoids. Archives of Biochemistry and Biophysics 345:305-310. Cerca con Google

125. Ingelman-Sundberg M (2002) Polymorphism of cytochrome P450 and xenobiotic toxicity. Toxicology 181-182:447-452. Cerca con Google

126. Ingelman-Sundberg M, Sim SC, Gomez A and Rodriguez-Antona C (2007) Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects. Pharmacology & Therapeutics 116:496-526. Cerca con Google

127. Ioannides C (2002) Xenobiotic metabolism: an overview. In: Enzyme systems that metabolise drugs and other xenobiotics. WILEY. Chichester, West Sussex, UK, 1-29. Cerca con Google

128. Ioannides C (2006) Cytochrome P450 expression in the liver of food-producing animals. Current Drug Metabolism 7:335-348. Cerca con Google

129. Istasse I, De Haan V, Van Enaeme C, Buts B, Baldwin P, Gielen M, Demeter D and Bienfait JM (1989) Effects of dexamethasone injections on performance in a pair of monozygotic cattle twins. Journal of Animal Physiology and Animal Nutrition 62:150-158. Cerca con Google

130. Jang I, Chae K and Cho J (2001) Effects of age and strain on small intestinal and hepatic antioxidant defence enzymes in Wistar and Fisher 344 rats. Mechanism of Ageing and Development. 122:561-570. Cerca con Google

131. Jaspreet SS, Fei L, Curtis J and Omiecinski (2004) Phenobarbital responsiveness as a uniquely sensitive indicator of hepatocyte differentiation status: requirement of dexamethasone and extracellular matrix in establishing the functional integrity of cultured primary rat hepatocytes. Experimental Cell Research 292:252-264. Cerca con Google

132. Jones SA, Moore LB, Shenk JL, Wisely GB, Hamilton GA, McKee DD, Tomkinson NC, LeCluyse EL, Lambert MH, Willson TM, Kliewer SA and Moore JT (2000) The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Molecular Endocrinology 14:27-39. Cerca con Google

133. Juarez-Oropeiza MA, Lopez V, Alvarez-Fernandez G, Gomez Y and Pedernera E (1995) Androstenedione metabolism in the different stage of bovine gonad development. Journal of Experimental Zoology 271:373-378. Cerca con Google

134. Kadlubar FF and Hammons GJ (II Edizione 1987) The role of cytochrome P450 in the metabolism of chemical carcinogens. In: Guengerich FP, Mammalian cytochrome P450, CRC Press, Boca Raton and Florida, 81-130. Cerca con Google

135. Kaltenbach CC and Dunn TG (1984) Endocrinologia della riproduzione. In: Hafez E.S.E., Biologia e Tecnologia della Riproduzione nelle Specie Animali di Interesse Zootecnico, Editoriale Grasso, Bologna. Cerca con Google

136. Kamanga-Sollo E, Pampusch MS, Xi G, White ME, Hathaway MR and Dayton WR (2004) IGF-I mRNA levels in bovine satellite cells cultures: effects of fusion and anabolic steroid treatment. Journal of Cell Physiology 201:181-189. Cerca con Google

137. Kaplan JC and Delpech M (1995) I vettori: plasmidi, fagi, cosmidi, YAC, virus. In: Biologia Molecolare e Medicina, Idelson-Gnocchi G. Editore, Napoli, 517-536. Cerca con Google

138. Karlsson HJ, Lincoln P and Westman G (2003) Synthesis and DNA binding studies of a new asymmetric cyanine dye binding in the minor groove [poly(dA-dT)]2. Bioorganical and Medical Chemistry 11:1035-1040. Cerca con Google

139. Katoh M, Matsui T, Okumura H, Nakajima M, Nishimura M, Naito S, Tateno C, Yoshizato K and Yokoi T (2005) Expression of human phase II enzymes in chimeric mice with humanized liver. Drug Metabolism and Disposition 33:1333-1340. Cerca con Google

140. Kawajiiri K and Fujii-Kuriyama Y (2007) Cytochrome P450 gene regulation and physiological functions mediated by the aryl hydrocarbon receptor. Archives of Biochemistry and Biophysics 464:207-212. Cerca con Google

141. Kawamoto T, Kakizaki S, Yoshinari K and Negishi M (2000) Estrogen activation of the nuclear orphan receptor CAR (constitutive active receptor) in induction of the mouse Cyp2b10 gene. Molecular Endocrinology 14:1897-1905. Cerca con Google

142. Kedderis GL and Mugford CA (1998) Sex-dependent metabolism of xenobiotics. Drug Metabolism Reviews 30:441-498. Cerca con Google

143. Kent UM, Mills DE, Rajnarayanan RV, Alworth WL and Hollenberg PF (2002) Effect of 17- ?-ethynylestradiol on activities of cytochrome P450 2B (P450 2B) enzymes: characterization of inactivation of P450s 2B1 and 2B6 and identification of metabolites. The Journal of Pharmacology and Experimental Therapeutics 300:549-558. Cerca con Google

144. Kiku Y, Matsuzawa H, Ohtsuka H, Terasaki N, Furuka S, Kon-Nai S, Koiwa M, Yokomizo Y, Sato H, Rosol TJ, Okada H and Yoshino TO (2002) Effects of chlorpromazine, pentoxifylline and dexamethasone on mRNA expression of lipopolysaccaride-induced inflammatory cytokines in bovine peripheral blood mononuclear cells. The Journal of Veterinary Medical Science 64:723-726. Cerca con Google

145. Kim YC, Yim HK, Jung YS, Park JH and Kim SY (2007) Hepatic injury induces contrasting response in liver and kidney to chemicals that are metabolically activated: role of male sex hormones. Toxicology and Applied Pharmacology 223:56-65. Cerca con Google

146. Kiyosawa N, Kwekel JC, Burgoon LD, Williams KJ, Tashiro C, Chittim B and Zacharewski TR (2008) o,p’-DDT elicits PXR/CAR, not ER, mediated responses in the immature, ovariectomized rat liver. Toxicological Sciences 101:350-363. Cerca con Google

147. Klingenberg M (1958) Pigment of rat liver microsomes. Archives of Biochemistry and Biophysics 75:376-386. Cerca con Google

148. Klinger W, Lupp A, Karge E, Baumbach H, Eichhorn F, Feix A, Fuldner F, Gernhardt S, Knels L, Kost B, Mertens G, Werner F, Oettel M, Römer W, Schwarz S, Elger W and Schneider B (2002) Estradiol, testosterone, dehydroepiandrosterone and androstenedione: novel derivatives and enantiomers. Interactions with rat liver microsomal cytochrome P450 and antioxidant/radical scavenger activities in vitro. Toxicology Letters 128:129-144. Cerca con Google

149. Kniewald J, Kmetic I, Gaurina-Srcek V and Knievald Z (2005) Alternative models for toxicity testing of xenobiotics. Arhiv za Higijenu Rada I Toksikologiju 56:195-204. Cerca con Google

150. Kocarek TA, Schuetz EG, Strom SC, Fisher RA and Guzelian PS (1995) Comparative analysis of cytochrome P4503A induction in primary cultures of rat, rabbit, and human hepatocytes. Drug Metabolism and Disposition 23:415-421. Cerca con Google

151. Kohalmy K, Tamási V, Kóbori L, Sárváry E, Pascussi JM, Porrogi P, Rozman D, Prough RA, Meyer UA and Monostory K (2007) Dehydroepiandrosterone induces human CYP2B6 through the constitutive androstane receptor. Drug Metabolism and Disposition 35:1495-1501. Cerca con Google

152. Krüger KA, Blum JW and Greger DL (2005) Expression of nuclear receptor and target genes in liver and intestine of neonatal calves fed colostrum and vitamin A. Journal of Dairy Science 88:3971-3981. Cerca con Google

153. Kubista M, Andrade JM, Bengtsson M, Forootan A, Jonák J, Lind K, Sindelka R, Sjöback R, Sjögreen B, Strömbom L, Ståhlberg A and Zoric N (2006) The real-time polymerase chain reaction. Molecular Aspects of Medicine 27:95-125. Cerca con Google

154. Kuilman MEM, Maas RFM and Fink-Gremmels J (2000) Cytochrome P450-mediated metabolism and cytotoxicity of aflatoxin B1 in bovine hepatocytes. Toxicology In Vitro 14:321-327. Cerca con Google

155. Kuilman MEM, Maas RFM, Judah DJ and Fink-Gremmels J (1998) Bovine hepatic metabolism of aflatoxin B1. Journal of Agricultural Food and Chemistry 46:2707-2713. Cerca con Google

156. Kuiper HA, Noordam MY, van Dooren-Flipsen MMH, Schilt R and Roos AH (1998) Illegal use of ß-adrenergic agonists: European Community. Jounal of Animal Science 76:195-207. Cerca con Google

157. Kunieda T, Maruyama M, Okitsu T, Shibata N, Takesue M, Totsugawa T, Kosaka Y, Arata T, Kobayashi K, Ikeda H, Oshita M, Nakaji S, Ohmoto K, Yamamoto S, Kuabayashi Y, Kadama M, Tanaka N and Kobayashi N (2003) Cryopreservation of primarily porcine hepatocyte with UW solution. Cell Transplantation 12:607-616. Cerca con Google

158. Kutyavin IV, Afonina IA, Mills A, Gorn VV, Lukhtanov EA, Belousov ES, Singer MJ and Walburger DK (2000) 3’-Minor Groove Binder-DNA probes increase sequence specificity at PCR extension temparatures. Nucleic Acids Research 28:655-661. Cerca con Google

159. Labrie F, Luu-The V, Martel C, Chernomoretz A, Calvo E, Morisette J and Labrie C (2006) Dehydroepiandrosterone (DHEA) is an anabolic steroid like dihydrotestosterone (DHT), the most potent natural androgen, and tetrahydrotestosterone (THG). Journal of Steroid Biochemistry and Molecular Biology 100:52-58. Cerca con Google

160. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685. Cerca con Google

161. Larsson A, Calsson C and Jonsson M (1995) Characterization of the binding of YO to [poly(dA-dT)]2 and [poly(dG-dC)]2, and of the fluorescent properties of YO and YOYO complexed with the polynucleotides and double-stranded DNA. Biopolymers 36:153-167 Cerca con Google

162. LeCluyse E, Madan A, Hamilton G, Carroll K, DeHaan R and Parkinson A (2000) Expression and regulation of cytochrome P450 enzymes in primary cultures of human hepatocytes. Journal of Biochemical and Molecular Toxicology 14:177-188. Cerca con Google

163. Lee HY, Acosta TJ, Tanikawa M, Sakumoto R, Komiyama J, Tasaki Y, Piskula M, Skarzynsky DJ, Tetsuka M and Okuda K (2007) The role of glucocorticoid in the regulation of prostaglandin biosynthesis in no-pregnant bovine endometrium. Journal of Endocrinology 193:127-135. Cerca con Google

164. Lin HL, Kent UM and Hollenberg (2002) Mechanism-based inactivation of cytochrome P450 3A4 by 17 ?-ethynylestradiol: evidence for heme destruction and covalent binding to protein. The Journal of Pharmacology and Experimental Therapeutics 301:160-167. Cerca con Google

165. Lin JH (2003) Role of P-glycoprotein in drug metabolism and disposition. Drug Metabolism Review 35:13 Cerca con Google

166. Lison D (1999) Importance of biotransformation pathways for interpreting biological monitoring of exposure. Toxicology Letters 108:91-97. Cerca con Google

167. Liu PS and Wang PY (2004) DHEA attenuates catecholamine secretion from bovine adrenal chromaffin cells. Journal of Biomedical Science 11:200-205. Cerca con Google

168. Livak KJ and Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-??Ct Method. Methods 25:402-408. Cerca con Google

169. Löfgren S, Hagbjörk AL, Ekman S, Fransson-Steen R and Terelius Y (2004) Metabolism of human cytochrome P450 marker substrates in mouse: a strain and gender comparison. Xenobiotica 34:811-834. Cerca con Google

170. Lorenti A, Hidalgo AM, Barlich MR, Torres J, Batalle J, Izaguirre MF, Fiorucci MP, Casco V, Gadano A and Argibay PF (2006) Structural and functional polarity of porcine hepatocyte cultured spheroids. Acta Gastroenterologica Latinoamericana 36:66-75. Cerca con Google

171. Lowry O, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193:265-275. Cerca con Google

172. Lupp A, Glockner R, Danz M and Muller D (2002) Cryopreserved precision-cut rat liver slices: morphology and cytochrome P450 isoforms expression after prolonged incubation. Toxicology in vitro 16:749-758. Cerca con Google

173. Luu-The V (2001) Analysis and characteristics of multiple type of human 17ß-hydroxysteroid dehydrogenase. Journal of Steroid Biochemistry and Molecular Biology 76:143-151. Cerca con Google

174. Ma YZ, Ma ZQ, Gui CQ, Yao JS and Sun RY (2003) Hepatotoxicity and toxicokinetics of ketoconazole in rabbits. Acta Pharmacologica Sinica 24:778-782. Cerca con Google

175. Machala M, Sou?ek P, Ne?a J, Ulrich R, Lamka J, Szotáková B and Skálová L (2003) Interspecies comparisons of hepatic cytochrome P450 enzyme levels in male ruminants. Archives of Toxicology 77:555-560. Cerca con Google

176. Massirer KB and Pasquinelli AE (2006) The evolving role of microRNAs in animal gene expression. Bioassays 28:449-452. Cerca con Google

177. Mastrocola R, Aragno M, Betteto S, Brignardello E, Catalano MG, Danni O and Boccuzzi G (2003) Pro-oxidant effect of dehydroepiandrosterone in rats is mediated by PPAR activation. Life Sciences 73:289-299. Cerca con Google

178. Mazel P (1971) Experiments illustrating drug metabolism in vitro. In Fundamentals of drug metabolism and drug disposition. (Ladu BN, Mandel MG and Way EL, Eds), 569-572. Cerca con Google

179. McCune JS (2000) In vivo and in vitro induction of human cytochrome P4503A4 by dexamethasone. Clinical Pharmacology and Therapeutics 68:356-366. Cerca con Google

180. Merlanti R (2005) Trattamenti ormonali nel vitello a carne bianca: effetti a carico delle attività farmaco-metabolizzanti epatiche citocromo P450-dipendenti ed identificazione di biomarker urinari di trattamento. Tesi di Dottorato, Padova. Cerca con Google

181. Merlanti R, Carletti M, De Bona C, Capolongo F, Nebbia C, Poppi L, Dacasto M and Montesissa C (2006) Influence of diets containing animal or plant sterols and a boldenone/boldione combination on liver drug metabolism in veal calves. Journal of Veterinary Pharmacology and Therapeutics 29:126-127. Cerca con Google

182. Merlanti R, Gallina G, Capolongo F, Contiero L, Biancotto G, Dacasto M and Montesissa C (2007) An in vitro study on metabolism of 17beta-boldenone and boldione using cattle liver and kidney subcellular fractions. Analytica Chimica Acta 586:177-183. Cerca con Google

183. Meyer HH (2001) Biochemistry and physiology of anabolic hormones used for improvement of meat production Acta Phatologica, Microbiologica et Immunologica Scandinavia 109:1-8. Cerca con Google

184. Meyer HHD and Rinke LM (1991) The pharmacokinetics and residues of clenbuterol in veal calves. Journal of Animal Science 69:4538-4544. Cerca con Google

185. Meystre C, Frey H, Voser W and Wettstein A (1956) Gewinnung von 1;4-Bisdehydro-3-oxo-steroiden. Uber Steroide, 139. Mitteilung. Helvetica Chimica Acta 39:734-742. Cerca con Google

186. Miller NE and Halpert J (1986) Analogs of chloramphenicol as mechanism-based inactivators of rat liver cytochrome P-450: modifications of propanediol side chain, the p-nitro group and the dichloromethyl moiety. Molecular Pharmacology 29:391-398. Cerca con Google

187. Montesissa C, Anfossi P, Van’t Klooster G and Mengelers M (1996) The use of cultured hepatocytes from goats and cattle to investigate oxidative metabolism. Veterinary Research Communications 20:449-460. Cerca con Google

188. Montesissa C, Capolongo F, Santi A, Biancotto G and Dacasto M (2004) Metabolism of tilmicosin by rabbit liver microsomes and hepatocytes. Veterinary Journal 167:87-94. Cerca con Google

189. Morales AJ, Haubrich RH, Hwang JY, Asakura H and Yen SSC (1998) The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. Clinical Endocrinology 49:421-439. Cerca con Google

190. Morrison TB, Weis JJ and Wittwer CT (1998) Quantification of low-copy transcripts by continous SYBR Green I monitoring during amplification. Biotecniques 24:954-962. Cerca con Google

191. Mullis K, Faloona F, Scharf S, Saiki R, Horn G and Erlich H (1986) Specific enzymatic amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harbor symposia on quantitative biology 51:263-273. Cerca con Google

192. Mutembei HM, Pesch S, Schuler G and Hoffmann B (2005) Expression of oestrogen receptor α and β and of aromatase in the testis of immature and mature boars. Reproduction in Domestic Animal 40:228-236. Cerca con Google

193. Muto N, Hirai H, Tanaka T, Itoh N and Tanaka K (1997) Induction and inhibition of cytochrome P450 isoforms by imazalil, a food contaminant, in mouse small intestine and liver. Xenobiotica 27:1215-1223. Cerca con Google

194. Nagar S and Remmel RP (2006) Uridine diphosphoglucuronosyltransferase pharmacogenetics and cancer. Oncogene 25:1659-1672. Cerca con Google

195. Nahmias Y, Berthiaume F and Yarmush ML (2006) Integration of technologies for hepatic tissue engineering. Advance in Biochemical Engineering/Biotechnology 103:309-329. Cerca con Google

196. Nakajima M, Iwanari M and Yokoi T (2003) Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inducible expression of the human CYP1 family in MCF-7 and HeLa cells. Toxicology Letters 144:247-256. Cerca con Google

197. Nakajima M, Tane K, Nakamura S, Shimada N, Yamazaki H and Tokoi T (2002) Evaluation of approach to predict the contribution of multiple cytochrome P450s in drug metabolism using relative activity factor: effects of the differences in expression levels of NADPH-cytochrome P450 reductase and cytochrome b(5) in the expression system and the differences in the marker activities. Journal of Pharmacological Sciences 91:952-963. Cerca con Google

198. Nakata K, Tanaka Y, Nakano T, Adachi T, Tanaka H, Kaminuma T and Ishikawa T (2006) Nuclear-receptor-mediated transcriptional regulation in phase I, II and III xenobiotic metabolizing enzymes. Drug Metabolism and Pharmacokinetics 21:437-457. Cerca con Google

199. Narasaka T, Moriya T, Endoh M, Suzuki T, Shizawa S, Mizokami Y, Matsuoka T and Sasano H (2000) 17beta-hydroxysteroid dehydrogenase type 2 and dehydroepiandrosterone sulfotransferase in the human liver. Endocrinology Journal 47:697-705. Cerca con Google

200. Nawata H, Yanase T, Goto K, Okabe T and Ashida K (2002) Mechanism of action of anti-ageing DHEA-S and the replacement of DHEA-S. Mechanism of Ageing and Development 123:1101-1106. Cerca con Google

201. Nebbia C (2001) Biotrasformation enzymes as determinants of xenobiotic toxicity in domestic animals. Veterinary Journal 161:238-252. Cerca con Google

202. Nebbia C (2005) Trattamenti illeciti con steroidi sessuali, corticosteroidi e beta-agonisti: rischi per il consumatore e nuovi approcci diagnostici. Workshop: “Residui negli alimenti di origine animale: analisi del rischio, prevenzione e sorveglianza”. ISTISAN Conference. Istituto Superiore di Sanità, 19-20 Dicembre 2005. Roma, Italia Cerca con Google

203. Nebbia C , Dacasto M and Carletti M (2004) Postnatal development of hepatic oxidative, hydrolytic and conjugative drug-metabolizing enzymes in female horses. Life Science 74:1605-1619. Cerca con Google

204. Nebbia C, Dacasto M, Rossetto Giaccherino A, Giuliano Albo A and Carletti M (2003) Comparative expression of liver cytochrome P450-dependent monooxygenases in the horse and in other agricultural and laboratory species. Veterinary Journal 165:53-64. Cerca con Google

205. Nebbia C, Dacasto M, Soffietti MG, Rasero R, Principato GB and Di Simplicio P (1993) Inhibition of hepatic xenobiotic metabolism and of glutathione-dependent enzyme activities by zinc ethylene-bis-dithiocarbamate in the rabbit. Pharmacology and Toxicology 73:233-239. Cerca con Google

206. Nebert DW and Gelboin HV (1968) substrate-inducible microsomal aryl hydrocarbon hydroxylase in mammalian cell culture. I. Assay and properties of the induced enzyme. Journal of Biological Chemistry 243:6242-6249. Cerca con Google

207. Nebert DW and Roe Al (2000) Ethnic and genetic differences in metabolism genes and risk of toxicity and cancer. The Science of the Total Environment 274:93-102. Cerca con Google

208. Nebert DW, Nelson DR, Adesnik M, Coon MJ, Estabrook RW, Gonzalez FJ, Guengerich FP, Gunsalup IC, Johnson EF, Kemper B, Levin W, Phillips IR, Sato R and Waterman MR (1989) The P450 superfamily: updated listing of all genes and recommended nomenclature for the chromosomal loci. DNA and Cell Biology 8:1-13. Cerca con Google

209. Nebert DW, Nelson DR, Coon MJ, Estabrook RW, Feyereisen R, Fujii-Kurijama Y, Gonzalez FJ, Guengerich FP, Gunsalup IC, Johnson EF, Loper JC, Sato R, Waterman MR and Waxman D (1991) The P450 superfamily: updated on new sequences, gene mapping recommended nomenclature. DNA and Cell Biology 10:1-14. Cerca con Google

210. Nelson DR, Koymans L, Kamataki T, Stegeman JJ, Feyereisen R, Waxman DJ, Waterman MR, Gotoh O, Coon MJ, Estabrook RW, Gunsalus IC and Nebert DW (1996) The P450 superfamily: updated on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6:1-42. Cerca con Google

211. Nims RW, Prough RA, Jones CR, Stockus DL, Dragnev KH, Thomas PE and Lubet RA (1997) In vivo induction and in vitro inhibition of hepatic cytochrome P450 activity by the benzodiazepine anticonvulsivants clonazepam and diazepam. Drug Metabolism and Disposition 25:750-756. Cerca con Google

212. Nowell S and Falany CN (2006) Pharmacogenetics of human cytosolic sulfotransferases. Oncogene 25:1673-1678. Cerca con Google

213. O’Donnel L, Robertson KM, Jones ME and Simpson ER (2001) Estrogen and spermatogenesis. Endocrine Reviews 22:289-318. Cerca con Google

214. Oesch-Bartlomowicz B and Oesch F (2005) Phosphorylation of cytochromes P450: first discovery of a posttranslational modification of a drug-metabolizing enzyme. Biochemical and Biophysical Research Communications 338:446-449. Cerca con Google

215. Okino ST, Pookot D, Li LC, Zhao H, Urakami S, Shiina H, Igawa M and Dahiya R (2006) Epigenetic inactivation of the dioxin-responsive cytochrome P4501A1 gene in human prostate cancer. Cancer Research 66:7420-7428. Cerca con Google

216. Okita RT and Okita JR (2001) Cytochrome P450 4A fatty acid omega hydroxylases. Current Drug Metabolism 2:265-281. Cerca con Google

217. Omura T e Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. The Journal of Biological Chemistry 239: 2370-2378. Cerca con Google

218. Opherk C, Tronche F, Kellendonk C, Kohlmuller D, Schulze A, Schmid W and Schutz G (2004) Inactivation of glucocorticoid receptor in hepatocytes leads to fastin hypoglycaemia and ameliorates hyperglicaemia in streptozotocin-induced diabetes mellitus. Molecular Endocrinology 18:1346-1353. Cerca con Google

219. Paine AJ (1996) Validity and reliability of in vitro systems in safety evaluation. Environmental Toxicology and Pharmacology 2:207-212. Cerca con Google

220. Palmer S, Wiegand AP, Maldarelli F, Bazmi H, Mican JM, Polis M, Dewar RL and Planta A (2003) New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. Journal of Clinical Microbiology 41:4531-4563. Cerca con Google

221. Pampori NA and Shapiro BH (1993) Sexual dimorphism in avian hepatic monooxigenases. Biochemical Pharmacology 46:885-890. Cerca con Google

222. Parikka V, Peng Z, Hentunen T, Risteli J, Elo T, Väänänen HK and Härkönen P (2005) Estrogen responsiveness of bone formation in vitro and altered bone phenotype in aged estrogen receptor-?-deficient male and female mice. European Journal of Endocrinology 152:301-314. Cerca con Google

223. Park KS, Sohn DH, Veech RL and Song BJ (1993) Translational activation of ethanol-inducible cytochrome P450 2E1 (CYP2E1) by isoniazid. European Journal of Pharmacology 248:7-14. Cerca con Google

224. Parkinson A (VI Edizione 2001) Biotransformation of xenobiotics. In: Klaassen CD, Casarett & Doull’s Toxicology, the basic science of poisons, Mc Graw Hill, New York, 133-224. Cerca con Google

225. Pasanen M (2004) Species differences in CYP enzymes. In: Cascales Angosto M, Gómez-Lechón MJ, Citocromo P-450, Istituto de España, Real Accademia Nacional de Farmacia, Realigraf S.A., Madrid, España. Cerca con Google

226. Pascussi JM, Drocourt L, Fabre JM, Maurel P and Vilarem MJ (2000a) Dexamethasone induces pregnane X receptor and retinoid X receptor-? expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators. Molecular Pharmacology 58:361-372. Cerca con Google

227. Pascussi JM, Drocourt L, Gerbal-Chaloin S, Fabre JM, Maurel P and Vilarem MJ (2001) Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes. European Journal of Biochemistry 268: 6346-6357. Cerca con Google

228. Pascussi JM, Gerbal-Chaloin S, Fabre JM, Maurel P and Vilarem MJ (2000b) Dexamethasone enhances constitutive androstane receptor expression in human hepatocytes: consequences on Cytochrome P450 gene regulation. Molecular Pharmacology 58:1441-1450. Cerca con Google

229. Pascussi JM,. Gerbal-Chaloin S, Drocourt L, Maurel P and Vilarem MJ (2003) The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle networks of nuclear and steroid receptors Biochimica and Biophysica Acta 1619:243-253. Cerca con Google

230. Peffer RC, Moggs JG, Pastoor T, Currie RA, Wright J, Milburn G, Waechter F and Rusyn I (2007) Mouse liver effects of cyproconazole, a triazole fungicide: role of the constitutive androstane receptor. Toxicological Science 99:315-325. Cerca con Google

231. Pegolo S, Merlanti R, Giantin M, Dacasto M, Montesissa C and Capolongo F (2007) Validation of HPLC determination of CYP1A and CYP2C activities in bovine liver microsomes. Journal of Chromatography B (submitted) Cerca con Google

232. Pelkonen O (2004) Induction of CYP enzymes. In: Cascales Angosto M, Goméz-Lechón MJ, 2004. Citocromo P-450 Instituto de España, Real Accademia Nacional de Farmacia, Realigraf S.A., Madrid, España, 126-127. Cerca con Google

233. Pelkonen O, Mäenpää J, Taavitsainen P, Rautio A and Raunio H (1998) Inhibition and induction of human cytochrome P450 (CYP) enzymes. Xenobiotica 28:1203-1253. Cerca con Google

234. Peters IR, Helps CR, Hall EJ and Day MJ (2004) Real-time RT-PCR: considerations for efficient and sensitive assay design. Journal of Immunological Methods. 286:203-217. Cerca con Google

235. Piersma AH (2006) Alternative methods for developmental toxicity testing. Basic Clinical Pharmacology 98:427-431. Cerca con Google

236. Poelmans S, Schilt R, Stephany RW, Le Bizec B, Draisci R, Sterk S, Van Ginkel LA, Courtheyn D, Van Hoof N, Lucentini L, De Wasch K and De Brabander HF (2003) EU expert report on boldenone: state of the art, 13 May 2003. Cerca con Google

237. Poli G, Cocilovo A, Dall’Ara P, Martino PA and Ponti W (II edizione, 2005) Western blotting (Immunoblotting). In: Microbiologia e immunologia veterinaria, UTET, Stamperia Artistica Nazionale, Torino, 688-689. Cerca con Google

238. Presidente della Repubblica Italiana, Decreto Legislativo n. 336 del 4 agosto 1999. Gazzetta Ufficiale n.230 del 30 Settembre 1999. Cerca con Google

239. Presidente della Repubblica Italiana, Decreto Legislativo n.158 del 16 marzo 2006. Gazzetta Ufficiale n.98 del 28 Aprile 2006. Cerca con Google

240. Prough RA, Linder MW, Pinaire JA, Xiao GH and Falkner KC (1996) Hormonal regulation of hepatic enzymes involved in foreign compound metabolism. FASEB Journal 10:1369-1377. Cerca con Google

241. Reed R, Holmes D, Weyers J and Jones A (I Edizione 2002) Genetica molecolare III: tecniche di ingegneria genetica. In: Metodologie di base per le scienze biomolecolari, Zanichelli, Bologna. Cerca con Google

242. Reinke LA and Moyer MJ (1985) p-Nitrophenol hydroxylation. A microsomal oxydation which is highly inducible by ethanol. Drug Metabolism and Disposition 13:548-552. Cerca con Google

243. Reiter M, Walf VM, Christians A, Pfaffl MW and Meyer HHD (2007) Modification of mRNA expression after treatment with anabolic agents and the usefulness for gene expression-biomarkers. Analytica Chimica Acta 586:73-81. Cerca con Google

244. Rekka E, Evdokimova E, Eeckhoudt S, Labar G and Calderon PB (2002) Role of temperature on protein and mRNA P450 3A (CYP3A) isozymes expression and midazolam oxidation by cultured rat precision-cut liver slices. Biochemical Pharmacology 64:633-643. Cerca con Google

245. Rijk J, Baykus H, van Hende J, Peijnenburg A, Groot M and Nielen M (2006) Changes in gene expression profiles of bovines treated with the prohormone dehydroepiandrosterone (DHEA), using a bovine DNA micro-array. Proceedings of the 5th International Symposium on hormone and veterinary drug residue analysis, May 16th — 19th, 2006, Antwerp, Belgium, 194. Cerca con Google

246. Ririe KM, Rasmussen RP and Wittwer CT (1997) Product differentiation by analysis of DNA melting curves during the polymerase chain reaction. Analytical Biochemistry 245:154-160. Cerca con Google

247. Rutledge RG and Côté C (2003) Mathematics of quantitative kinetic PCR and the application of standard curves. Nucleic Acids Research 31(16) Cerca con Google

248. Rutten AJJL, Falke HE, Catsburg JF, Top R, Blaaboer BJ, Van Holsteijn I, Doorn L and Van Leeuwen FXR (1987) Interlaboratory comparison of total cytochrome P-450 and protein determinations in rat liver microsomes. Archives of Toxicology 61:27-33. Cerca con Google

249. Saito K, Sakai N, Kim HS, Ishizuka M, Kazusaka A and Fujita S (2004) Strain differences in diazepam metabolism at its three metabolic sites in Sprague-Dawley, Brown Norway, Dark Agouti and Wistar strain rats. Drug Metabolism and Disposition 32:959-965. Cerca con Google

250. Sakuma T, Yokoi T and Kamataki T (1995) Isolation and characterization of a new cDNA clone belonging to the cytochrome P450 2C gene subfamily in hamsters. Archives of Biochemistry and Biophysics. 319:267-273. Cerca con Google

251. Sallovitz J, Lifschitz A, Imperiale F, Pis A, Virkel G and Lanusse C (2002) Breed differences on the plasma availability of moxidectin administered pour-on to calves. Veterinary Journal 164:47-53. Cerca con Google

252. Sanderson T and Van Den Berg M (2003) Interactions of xenobiotics with the steroid hormone biosynthesis pathway. Pure and Applied Chemistry 75:1957-1971. Cerca con Google

253. Sawada M and Kamataki T (1998) Genetically engeneered cells stably expressing cytochrome P450 and their application to mutagen assays. Mutation Research 411:19-43. Cerca con Google

254. Scheller K and Sekeris CE (2003) The effects of steroid hormones on the transcription of genes encoding enzymes of oxidative phosphorylation. Experimental Physiology 88:129-140. Cerca con Google

255. Schenkman JB and Jansson I (2003) The many roles of cytochrome b5. Pharmacology and Therapeutics 97:139-152. Cerca con Google

256. Schmidely P (1993) Quantitative bibliographic review on the use of anabolic hormones with steroidogenic action in ruminants for meat production. II. Principal mode of action. Reproduction, Nutrition, Development 33:297-323. Cerca con Google

257. Schnelzer E, Acikopez A, Fruhauf NR, Crome O, Klempnauer J, Christianus U and Bader A (2006) Biotransformation of cyclosporine in primary rat, porcine and human liver cell co-coltures. Xenobiotica 36:693-708. Cerca con Google

258. Schuler G, Ozalp GR, Hoffmann B, Harada N, Browne P and Conley AJ (2006) Reciprocal expression of 17?-hydroxylase-C17,20-lyase and aromatase cytochrome P450 during bovine trophoblast differentiation: a two-cell system drives placental oestrogen synthesis. Reproduction 131:669-679. Cerca con Google

259. Schwerin M, Kuehn C, Wimmers S, Walz C and Goldammer T (2006) Trait-associated expressed hepatic and intestine genes in cattle of different metabolic type — putative functional candidates for nutrient utilization. Journal of Animal Breeding and Genetics 123:307-314. Cerca con Google

260. Seglen PO (1976) Preparation of isolated rat liver cells. Methods in Cell Biology 23:29-83. Cerca con Google

261. Sheweita SA (2000) Drug-metabolizing enzymes: mechanisms and functions. Current Drug Metabolism 1:107-132. Cerca con Google

262. Shibuya M, Echizen H, Kubo S, Tamura N, Suzuki K, Ushiama H and Ohnishi A (2003) Reduced urinary 6beta-hydroxycortisol to cortisol ratios in patients with liver cirrhosis. Hepathology Research 26:28-33. Cerca con Google

263. Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP and Sutter TR (1996) Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Research 56:2979-2984. Cerca con Google

264. Simpson AE (1997) The cytochrome P450 4 (CYP4) family. General Pharmacology 28:351-359. Cerca con Google

265. Simpson DA, Feeney S, Boyle C and Stitt AW (2000) Retinal VEGF mRNA measure by SYBR Green I fluorescence: a versatile approach to quantitative PCR. Molecular Vision 6:178-183. Cerca con Google

266. Sinclair J, Jeffery E, Wrighton S, Kostrubsky V, Szakacs J, Wood S and Sinclair P (1998) Alcohol-mediated increases in acetaminophen hepatotoxicity. Role of CYP2E and CYP3A. Biochemical Pharmacology 55:1557-1565. Cerca con Google

267. Sinclair PA, Hancorck S, Gilmore WJ and Squires EJ (2005) Metabolism of the 16-androstene steroids in primary cultured porcine hepatocytes. Journal of Steroid Biochemistry and Molecular Biology 96:79-87. Cerca con Google

268. Sipes G and Gandolfi AJ (III Edizione 1986) Biotransformation of toxicants In: Klassen CD, Amdur MO and Doull J, Toxicology. The basic science of poisons, Mac Millan, New York, 694-778. Cerca con Google

269. Sivapathasundaram S, Magnisali P, Coldham NG, Howells LC, Sauer MJ and Ioannides C (2001) A study of the expression of the xenobiotic-metabolising cytochrome P450 proteins and testosterone metabolism in bovine liver. Biochemical Pharmacology 62:635-645. Cerca con Google

270. Sivapathasundaram S, Magnisali P, Coldham NG, Howells LC, Sauer MJ and Ioannides C (2003a) Cytochrome P450 expression and testosterone metabolism in the liver of deer. Toxicology 187:49-65. Cerca con Google

271. Sivapathasundaram S, Sauer MJ and Ioannides C (2003b) Xenobiotic conjugation system in deer compared with cattle and rat. Comparative Biochemistry and Physiology Part C. 134:169-173. Cerca con Google

272. Stabenfeldt GH (2002) Attività riproduttiva della femmina. In: Swenson MJ, Reece WO, Duke’s Fisiologia degli Animali Domestici, Idelson-Gnocchi, Italia Cerca con Google

273. Stott WT, Kan HL, McFadden LG, Sparrow BR and Gollapudi BB (2004) Effect of strain and diet upon constitutive and chemically induced activities of several xenobiotic metabolizing enzymes in rats. Regulatory Toxicology and Pharmacology 39:325-333. Cerca con Google

274. Suzuki T, Sasano H, Andersson S and Mason JI (2000) 3ß-hydroxysteroid dehydrogenase/?5 ? ?4 -isomerase activity associated with the human 17ß-hydroxysteroid dehydrogenase type 2 isoform. The Journal of Clinical Endocrinology and Metabolism 85:3669-3672. Cerca con Google

275. Szotáková B, Baliharová V, Lamka J, Nožinová E, Wsól V, Velík J, Machala M, Ne?a J, Sou?ek P, Šusová S and Skálová L (2004) Comparison of in vitro activities of biotransformation enzymes in pig, cattle, goat and sheep. Research in Veterinary Science 76:43-51. Cerca con Google

276. Taniguchi S, Yanase T, Haji M, Ishibashi K, Takayanagi R and Nawata H (1995) Tha antiobesity effect of dhydroepiandrosterone in castrated or noncastrated obese Zucker male rats. Obesity Research 3:639-643. Cerca con Google

277. Testai E (2001) The drug-metabolizing enzyme system and the experimental tools used for in vitro toxicology for metabolic studies. Cell Biology and Toxicology 17:272-285. Cerca con Google

278. Thomas RJ, Bhandari R, Barrett DA, Bennett AJ, Fry JR, Powe D, Thomson B and Shakesheff KM (2005) The effect of three-dimensional co-culture of hepatocytes and hepatic stellate cells on key hepatocyte functions in vitro. Cell Tissue Organs 181:67-79. Cerca con Google

279. Thomford PJ and Dziuk PJ (1986) The influence of dose of Phenobarbital and intervals to measurement on concentration of liver enzymes in barrows and gilts. Journal of Animal Science 63:1184-1190. Cerca con Google

280. Timbrell JA (1982) Principles of biochemical toxicology, Taylor and Francis, London. Cerca con Google

281. Timbrell JA (1998) Biomarkers in toxicology. Toxicology 129:1-12. Cerca con Google

282. Toffolatti L, Gastaldo LR, Patarnello T, Romualdi C, Merlanti R, Montesissa C, Poppi L, Castagnaro M and Bargelloni L (2005) Expression analysis of androgen-responsive genes in the prostate of veal calves treated with anabolic hormones. Domestic Animal Endocrinology 30:38-55. Cerca con Google

283. Tokizane T, Shiina H, Igawa M, Enokida H, Urakami S, Kawakami T, Ogishima T, Okino ST, Li LC, Tanaka Y, Nonomura N, Okuyama A and Dahiya R (2005) Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clinical Cancer Research 11:5793-5801. Cerca con Google

284. Totsuka S, Watanabe T, Koyanagi F, Tanaka K, Yasuda M and Manabe S (1999) Increase in urinary excretion of 6beta-hydroxycortisol in common marmosets as a marker of hepatic CYP3A induction. Archives of Toxicology 73:203-207. Cerca con Google

285. Towbin H, Staehelin T and Gordon J (1979) Electrophoretic transfert of proteins from polyacrilamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Science USA 76:4350-4354. Cerca con Google

286. Townsend AJ, Kiningham KK, St. Clair D, Tephly T, Morrow CS and Guemgerich FP (1999) Symposium overview: characterization of xenobiotic metabolizing enzyme function using heterologous expression systems. Toxicological Sciences 48:143-150. Cerca con Google

287. Tsuchiya Y, Nakajima M and Yokoi T (2005) Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Letters 227:115-124. Cerca con Google

288. Tsuchiya Y, Nakajima M, Takagi S, Taniya T, Yokoi T (2006) MicroRNA regulates the expression of human cytochrome P450 1B1. Cancer Research 66:9090-9098. Cerca con Google

289. Tugwood JD, Hollins LE and Cockerill MJ (2003) Genomics and the search for novel biomarkers in toxicology. Biomarker 8:79-92 Cerca con Google

290. Tuschl G and Mueller O (2006) Effects of cell culture conditions on primary rat hepatocytes - Cell morphology and differential gene expression. Toxicology 218:205-215. Cerca con Google

291. Tyagi S and Kramer FR (1996) Molecular beacons: probes that fluoresce upon hybridization. Nature Biotecnology 14:303-308. Cerca con Google

292. Tydén E, Olsén L, Tallkvist J, Tjälve H and Larsson P (2007) Cytochrome P4503A, NADPH cytochrome P450 reductase and cytochrome b5 in the upper airways in horse Research in Veterinary Science (doi:10.10167/j.rvsc.2007.09.012). Cerca con Google

293. Vainio H (1998) Use of biomarkers - new frontiers in occupational toxicology and epidemiology. Toxicology Letters 102-103:581-589. Cerca con Google

294. Van Cromphaut SJ, Stockmans I, Torrekens S, Van Herck E, Carmeliet G and Bouillon R (2007) Duodenal calcium absorption in dexamethasone-treated mice: functional and molecular aspects. Archives of Biochemistry and Biophysics 460:300-305. Cerca con Google

295. Van Poucke C and Van Peteghem C (2002) Development and validation of multi-analyte method for the detection of anabolic steroids in urine with liquid chromatography-tandem mass spectrometry. Journal of Chromatography B 772:211-217. Cerca con Google

296. Van Puymbroeck M, Kullman MEM, Maas RFM, Witkamp RF, Leyssen L, Vanderzande D, Gelan J and Raus J (1998a) In vitro liver models are important tools to monitor the abuse of anabolic steroid in cattle. Analyst 123:2453-2456. Cerca con Google

297. Van Puymbroeck M, Kullman MEM, Maas RFM, Witkamp RF, Leyssen L, Vanderzande D, Gelan J and Raus J (1998b) Identification of some important metabolites of bol in urine and feces of cattle by GC-MS. Analyst 123:2681-2686. Cerca con Google

298. Van’t Klooster GAE (1992) Drug metabolism in ruminants and in vitro approach. Tesi di Dottorato, Wageningen. Cerca con Google

299. Van’t Klooster GAE, Blaauboer BJ, Noordhoek J and Van Miert ASJPAM (1993) Cytochrome P450 induction and metabolism of alkoxyresorufins, ethylmorphine and testosterone in cultured hepatocytes from goats, sheep and cattle. Biochemical Pharmacology 46:1781-1790. Cerca con Google

300. Van’t Klooster GAE, Woutersen-Van Nijnanten FMA, Klein WR, Blaauboer BJ, Noordhoek J and Van Miert ASJPAM (1992) Effects of various medium formulations and attachment substrata on the performance of cultured ruminant hepatocytes in biotransformation studies. Xenobiotica 22:523-534. Cerca con Google

301. Vegiopoulos A and Herzig S (2007) Glucocorticoids, metabolism and metabolic diseases. Molecular and Cellular Endocrinology 275:43-61 Cerca con Google

302. Vickers AE and Fisher RL (2005) Precision-cut organ slices to investigate target organ injury. Expert Opinion on Drug Metabolism and Toxicology 1:687-699. Cerca con Google

303. Wang H and LeCluyse EL (2003) Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes. Clinical Pharmacokinetics 42:1331-1357. Cerca con Google

304. Wang H, Huang M, Peng R and Le J (2006) Influences of 3-methylchloranthrene, phenobarbital and dexamethasone on xenobiotic metabolizing-related cytochrome P450 enzymes and steroidogenesis in human fetal adrenal cortical cells. Acta Pharmacologica Sinica 27:1093-1096. Cerca con Google

305. Wang X and Seed B (2003) A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Research 31:154-162. Cerca con Google

306. Waring JF and Halbert DN (2002) The promise of toxicogenomics. Current Opinion in Molecular Therapeutics 4:229-235. Cerca con Google

307. Warriss PD, Kestin SC, Rolph TP and Brown SN (1990) The effects of the beta-adrenergic agonist sulbutamol on meat quality in pigs. Journal of Animal Science 68:128-136. Cerca con Google

308. Wauthier V, Verbeeck RK and Calderon PB (2007) The effect of ageing on cytochrome P450 enzymes: consequences for drug biotransformation in the elderly. Current Medicinal Chemistry 14:745-757. Cerca con Google

309. Wendel A (2002) Do we need a “Chair of alternative methods”, and where? Altex 19:64-68. Cerca con Google

310. Weng Q, Tanaka Y, Taniyama H, Tunoda N, Nambo Y, Watanabe G and Taya K (2007) Immunolocalization of steroidogenic enzymes in equine fetal adrenal glands during mid-late gestation. Journal of Reproduction and Development 53:1093-1098. Cerca con Google

311. Werringloer J (1978) Assay of formaldehyde generated during microsomal oxidation reactions. Methods in Enzymology 52:297-302. Cerca con Google

312. Whitlock JP (1999) Induction of cytochrome P4501A1. Annual Review of Pharmacology and Toxicology 39:297-302. Cerca con Google

313. Williams ET, Leyk M, Wrighton SA, Davies PJA, Loose DS, Shipley GL and Strobel HW (2004) Estrogen regulation of the cytochrome P450 3A subfamily in humans. The Journal of Pharmacology and Experimental Therapeutics 311:728-735. Cerca con Google

314. Williams RT (II Edizione 1971) Detoxification Mechanism, Wiley, New York. Cerca con Google

315. Wilson WD, Tanious FA, Barton HJ, Jones RL, Fox K, Wydra RL, and Strekowski L (1990) DNA sequence dependent binding modes of 40,6-diamidino-2-phenylindole (DAPI). Biochemistry 29:8452-8461. Cerca con Google

316. Witkamp R (1992) Oxidative drug metabolism in ruminants and laboratory species. Tesi di Dottorato, Utrecht. Cerca con Google

317. Wong ML and Medrano F (2005) Real-time PCR for mRNA quantitation. Biotechniques 39:75-85. Cerca con Google

318. Wu L, Gu J, Cui H, Zhang QY, Behr M, Fang C, Weng Y, Kluetzman K, Swiatek PJ,, Yang W, Kaminsky L and Ding X (2005) Transgenic mice with a hypomorphic NADPH-cytochrome P450 reductase gene: effects on development, reproduction, and microsomal cytochrome P450. Journal of Pharmacology and Experimental Therapeutics 312:35-43. Cerca con Google

319. Xu C, Yong-Tao Li C and Tony Kong AN (2005) Induction of phase I, II and III drug metabolism/transport by xenobiotics. Archives of Pharmac Cerca con Google

Download statistics

Solo per lo Staff dell Archivio: Modifica questo record